BANK VONTOBEL/CALL/BIOGEN IDEC/330/0.1/20.09.24 | Delayed Deutsche Boerse AG 19:04:13 31/05/2024 BST | ||
| 0.072 EUR | +41.18% |
|
| 1 month | +213.04% | ||
| 3 months | -55.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 0.072 | +41.18% |
| 30/05/24 | 0.051 | +121.74% |
| 29/05/24 | 0.023 | -42.50% |
| 28/05/24 | 0.04 | +11.11% |
| 27/05/24 | 0.036 | -18.18% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 07:04 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM36AW |
| ISIN | DE000VM36AW4 |
| Date issued | 18/10/2023 |
| Strike | 330 $ |
| Maturity | 20/09/2024 (110 Days) |
| Parity | 10 : 1 |
| Emission price | 1.65 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.99 € |
|---|---|
| Lowest since issue | 0.001 € |
| Delta | 0.04x |
| Omega | 13.06 |
| Premium | 47.04x |
| Gearing | 303.05x |
| Moneyness | 0.6816 |
| Difference Strike | 105.1 $ |
| Difference Strike % | +31.84% |
| Spread | 0.021 € |
| Spread % | 26.58% |
| Intrinsic value | 0.000000 |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Warrants
- Warrant
